Needle-free drug delivery systems are a novel way to introduce various medicines into patients’ body and is anticipated to enhance the market. The Global Market is projected to grow at a CAGR of +8% By 2026 according to analysist at Healthcare Intelligence Markets
Needle-free drug delivery system is associated with a highly flexible technology that delivers medicines at an extraordinary speed. They can take the form of power sprays, inhalers, skin patches and also edible products. The aim of modern needle-free drug delivery system is to enhance the adoption of important medications that necessitates self-injection, such as insulins. For instance, Jet injectors have wide acceptance as they have limited the pain associated with occasional bruising. However, a major drawback is associated with the use of powdered drugs and PowderJect Pharmaceuticals is one of the pioneers to develop a needle-free technology for injecting powdered drugs into the skin. Micro and Nanotechnology has been in demand over the past few decades and this has been implemented in farm production systems that provide systematic immunization.
For Sample Copy of this report: https://www.healthcareintelligencemarkets.com/request_sample.php?id=29045
The leading participants operating in this market include Antares Pharma, Inc., Penjet Corporation, Injex Pharma AG, 3M, PharmaJet Inc., Zogenix, Inc., Valeritas, Glide Pharmaceutical Technologies Ltd., Bioject Medical Technologies, Inc., D’Antonio Consultants International, Inc., and Akra Dermojet amongst others.
The global needle-free drug delivery system is available in disposable and reusable forms, which has highly restricted the risk of cross-contamination from needle stick injury. This factor is responsible to drive the market’s growth. Poor compliance is resulting in long-term hindrance in the market’s growth. The rise in the number of chronic diseases has encouraged the proliferation of needle-free drug delivery devices usage. The insulin segment has been driving the market for a long period of time attributed to the growing occurrences of diabetic patients globally. The market players are striving to bring in safe and ergonomic platform device that can target a range of delivery volumes without affecting manufacturing and treatment costs.
Avail Discount on this report: https://www.healthcareintelligencemarkets.com/ask_for_discount.php?id=29045
Owing to the growing demand for these solutions, the North American region holds the highest market share and Asia Pacific region demonstrates to the fastest growing global market.
This market is demonstrating an inclination towards the self-administration and self-injection of several drugs in non-medical surroundings. DosePro® is a single-use, disposable, and pre-filled, needle-free subcutaneous conveyance system for self-injection of liquid drug formulations up to 0.5mL in volume, which also comprises of the large molecule and high viscosity formulations.
Needle-Free Drug Delivery Devices Market – by Application
- Vaccine Delivery
- Pain Management
- Insulin Delivery
- Pediatric Injections
Needle-Free Drug Delivery Devices Market – by Region
- North America
o The U.S.
o Rest of North America
o The UK
o Rest of Europe
- Asia Pacific
o Southeast Asia
o Rest of Asia Pacific
- The Middle East and Africa
o GCC Countries
o Southern Africa
o Rest of the Middle East and Africa